Supplementation with high-content docosahexaenoic acid triglyceride in attention-deficit hyperactivity disorder: a randomized double-blind placebo-controlled trial

Docosahexaenoic Acid ◽

Attention Deficit ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder

Journal of Developmental & Behavioral Pediatrics ◽

10.1097/00004703-200208000-00022 ◽

2002 ◽

Vol 23 (4) ◽

pp. 286

Author(s):

ADRIAN D. SANDLER

Keyword(s):

Docosahexaenoic Acid ◽

Attention Deficit ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Acid Supplementation ◽

A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder

The Journal of Pediatrics ◽

10.1067/mpd.2001.116050 ◽

2001 ◽

Vol 139 (2) ◽

pp. 189-196 ◽

Cited By ~ 204

Author(s):

Robert G. Voigt ◽

Antolin M. Llorente ◽

Craig L. Jensen ◽

J.Kennard Fraley ◽

Marcia C. Berretta ◽

...

Keyword(s):

Docosahexaenoic Acid ◽

Attention Deficit ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Acid Supplementation ◽

Methylphenidate Hydrochloride Modified-Release in Adults with Attention Deficit Hyperactivity Disorder: A Randomized Double-Blind Placebo-Controlled Trial

Advances in Therapy ◽

10.1007/s12325-013-0085-5 ◽

2013 ◽

Vol 31 (1) ◽

pp. 44-65 ◽

Cited By ~ 19

Author(s):

Michael Huss ◽

Ylva Ginsberg ◽

Torbjorn Tvedten ◽

Torben Arngrim ◽

Alexandra Philipsen ◽

...

Keyword(s):

Attention Deficit ◽

Controlled Trial ◽

Modified Release ◽

Double Blind ◽

Double Blind Placebo ◽

Pharmacotherapy of Attention Deficit Hyperactivity Disorder in Children: Results of a Multicenter, Double-Blind, Placebo-Controlled Trial of Hopantenic Acid

Neuroscience and Behavioral Physiology ◽

10.1007/s11055-018-0705-2 ◽

2018 ◽

Vol 49 (1) ◽

pp. 129-135 ◽

Cited By ~ 1

Author(s):

N. N. Zavadenko ◽

N. Yu. Suvorinova ◽

I. N. Vakula ◽

E. V. Malinina ◽

L. M. Kuzenkova

Keyword(s):

Attention Deficit ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

A Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of AR19, a Manipulation-Resistant Formulation of Amphetamine Sulfate, in Adults With Attention-Deficit/Hyperactivity Disorder

The Journal of Clinical Psychiatry ◽

10.4088/jcp.21m13927 ◽

2021 ◽

Vol 82 (5) ◽

Author(s):

Stephen V. Faraone ◽

Ann Childress ◽

Steve Caras ◽

Valerie K. Arnold ◽

C. Brendan Montano ◽

...

Keyword(s):

Attention Deficit ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder ◽

Amphetamine Sulfate

A Double-Blind, Placebo-Controlled Trial of Dexmethylphenidate Hydrochloride and d,l-threo-Methylphenidate Hydrochloride in Children With Attention-Deficit/Hyperactivity Disorder

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1097/01.chi.0000138351.98604.92 ◽

2004 ◽

Vol 43 (11) ◽

pp. 1406-1414 ◽

Cited By ~ 71

Author(s):

SHARON WIGAL ◽

JAMES M. SWANSON ◽

DAVID FEIFEL ◽

R BART SANGAL ◽

JOSEPHINE ELIA ◽

...

Keyword(s):

Attention Deficit ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Effect of atomoxetine on Tanner stage sexual development in children and adolescents with attention deficit/hyperactivity disorder: 18-month results from a double-blind, placebo-controlled trial

Current Medical Research and Opinion ◽

10.1185/03007995.2011.599372 ◽

2011 ◽

Vol 27 (sup2) ◽

pp. 45-52 ◽

Cited By ~ 2

Author(s):

Paula T. Trzepacz ◽

Thomas J. Spencer ◽

Shuyu Zhang ◽

Mark E. Bangs ◽

Michael M. Witte ◽

...

Keyword(s):

Children And Adolescents ◽

Attention Deficit ◽

Sexual Development ◽

Controlled Trial ◽

Tanner Stage ◽

Double Blind ◽

Double Blind Placebo ◽

Reduced inattention and hyperactivity and improved cognition after marine oil extract (PCSO-524®) supplementation in children and adolescents with clinical and subclinical symptoms of attention-deficit hyperactivity disorder (ADHD): a randomised, double-blind, placebo-controlled trial

Psychopharmacology ◽

10.1007/s00213-016-4471-y ◽

2016 ◽

Vol 234 (3) ◽

pp. 403-420 ◽

Cited By ~ 8

Author(s):

James D. Kean ◽

Jerome Sarris ◽

Andrew Scholey ◽

Richard Silberstein ◽

Luke A. Downey ◽

...

Keyword(s):

Children And Adolescents ◽

Attention Deficit ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Hyperactivity Disorder ◽

Oil Extract ◽

Inattention And Hyperactivity ◽

Subclinical Symptoms

Once-Daily Atomoxetine Treatment for Children With Attention-Deficit/Hyperactivity Disorder, Including an Assessment of Evening and Morning Behavior: A Double-Blind, Placebo-Controlled Trial

PEDIATRICS ◽

10.1542/peds.114.1.e1 ◽

2004 ◽

Vol 114 (1) ◽

pp. e1-e8 ◽

Cited By ~ 200

Author(s):

D. K. Kelsey

Keyword(s):

Attention Deficit ◽

Controlled Trial ◽

Double Blind ◽

Once Daily ◽

Double Blind Placebo ◽

Hyperactivity Disorder ◽

Atomoxetine Treatment

Efficacy and safety of saffron as adjunctive therapy in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled clinical trial

Advances in Integrative Medicine ◽

10.1016/j.aimed.2022.01.002 ◽

2022 ◽

Author(s):

Benyamin Pazoki ◽

Nadia Zandi ◽

Zeinab Assaf ◽

Hossein Sanjari Moghaddam ◽

Arefeh Zeinoddini ◽

...

Keyword(s):

Clinical Trial ◽

Attention Deficit ◽

Adjunctive Therapy ◽

Controlled Clinical Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽